Studies including local recurrence, T4 stage, BRCA1/2 (breast cancer 1/2) mutation, or de novo distant metastasis could have influenced DT4, 10, 26, 27, 28 (Figure 2). The gene discussed is BRCA1; the disease is breast carcinoma.